StockNews.AI
VTAK
StockNews.AI
218 days

Catheter Precision, Inc. Announces Initial LockeT Purchase From the University of Tennessee Medical Center

1. VTAK secures first order for LockeT in the southeast. 2. Company expands sales team ahead of national product launch.

2m saved
Insight
Article

FAQ

Why Bullish?

First purchase order indicates demand for LockeT, likely enhancing revenues. Similar scenarios in the past have led to stock price increases for medical device companies.

How important is it?

Successful launch and sales impact VTAK's market position and future earnings.

Why Short Term?

Immediate orders suggest near-term revenue growth. Historical trends show quick impacts post product launches.

Related Companies

VTAK
FORT MILL, SC / ACCESSWIRE / January 13, 2025 / Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced it has received its first purchase order for LockeT from the southeast region. As previously announced, the company has recently expanded its US sales and clinical team in preparation for the national product launch of LockeT.

Related News